Cellebrite DI Ltd (NASDAQ: CLBT) on Tuesday, soared 3.23% from the previous trading day, before settling in for the closing price of $18.55. Within the past 52 weeks, CLBT’s price has moved between $7.12 and $18.75.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Technology sector company grew by 18.79% over the past five years. The company achieved an average annual earnings per share of 51.35%. With a float of $61.62 million, this company’s outstanding shares have now reached $203.23 million.
Let’s look at the performance matrix of the company that is accounted for 1008 employees. In terms of profitability, gross margin is 84.19%, operating margin of 13.85%, and the pretax margin is -26.72%.
Cellebrite DI Ltd (CLBT) Insider and Institutional Ownership
Observing investor behavior towards Software – Infrastructure industry stocks is more important than anything else. The insider ownership of Cellebrite DI Ltd is 70.39%, while institutional ownership is 34.90%. The most recent insider transaction that took place on Oct 15 ’24, was worth 2,853,245. Before that another transaction happened on Sep 16 ’24, when Company’s Officer proposed sale 100,000 for $17.51, making the entire transaction worth $1,751,000.
Cellebrite DI Ltd (CLBT) Latest Financial update
According to the Wall Street analysts, stocks earnings will be around 51.35% per share during the next fiscal year.
Cellebrite DI Ltd (NASDAQ: CLBT) Trading Performance Indicators
Cellebrite DI Ltd (CLBT) is currently performing well based on its current performance indicators. A quick ratio of 1.69 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 10.99. Likewise, its price to free cash flow for the trailing twelve months is 43.96.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.53, a number that is poised to hit 0.07 in the next quarter and is forecasted to reach 0.30 in one year’s time.
Technical Analysis of Cellebrite DI Ltd (CLBT)
Cellebrite DI Ltd (NASDAQ: CLBT) saw its 5-day average volume 1.42 million, a positive change from its year-to-date volume of 1.13 million. As of the previous 9 days, the stock’s Stochastic %D was 83.25%. Additionally, its Average True Range was 0.55.
During the past 100 days, Cellebrite DI Ltd’s (CLBT) raw stochastic average was set at 92.53%, which indicates a significant increase from 69.90% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 22.04% in the past 14 days, which was lower than the 35.35% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $17.51, while its 200-day Moving Average is $13.13. Nevertheless, the first resistance level for the watch stands at $19.70 in the near term. At $20.24, the stock is likely to face the second major resistance level. The third major resistance level sits at $20.72. If the price goes on to break the first support level at $18.68, it is likely to go to the next support level at $18.20. The third support level lies at $17.66 if the price breaches the second support level.
Cellebrite DI Ltd (NASDAQ: CLBT) Key Stats
Market capitalization of the company is 3.98 billion based on 205,932K outstanding shares. Right now, sales total 325,110 K and income totals -81,100 K. The company made 95,710 K in profit during its latest quarter, and -23,810 K in sales during its previous quarter.
